Steffen Schuster
Directeur Général chez ITM Isotopen Technologien München AG
Profil
Steffen Schuster is currently the Chief Executive Officer at ITM Isotopen Technologien München AG and ITM Isotope Technologies Munich SE.
He is also the Co-Managing Director at ITG Isotope Technologies Garching GmbH and ITM Solucin GmbH.
Previously, he worked as the Director-Supervisory Board at Definiens AG, General Partner at TVM Capital GmbH, and Member-Supervisory Board at alfabet AG and iTAC Software AG.
Postes actifs de Steffen Schuster
| Sociétés | Poste | Début |
|---|---|---|
ITM Isotopen Technologien München AG
 ITM Isotopen Technologien München AG Miscellaneous Commercial ServicesCommercial Services ITM Isotopen Technologien München AG develops diagnostic and therapeutic radionuclides and radiopharmaceuticals. Its products include EnolucinBeta, 188w/188re generator, 255AC/213Bi Generator, IQS-TS, IQS, consumables, and GMP Radiolabeling service. The company was founded in 2004 and is headquartered in Garching, Germany. | Directeur Général | 01/12/2011 |
ITM Solucin GmbH
 ITM Solucin GmbH Miscellaneous Commercial ServicesCommercial Services ITM Solucin GmbH provides scientific research and development services. The private company is based in Garching, Germany. The CEOs of the German company are Steffen Schuster, Klaus Maleck, Konstantin Zhernosekov. | Directeur Général | - |
ITM Isotope Technologies Munich SE
 ITM Isotope Technologies Munich SE Pharmaceuticals: MajorHealth Technology ITM Isotope Technologies Munich SE is a German radiopharmaceutical biotech company that specializes in providing precise cancer radiotherapeutics and diagnostics to meet the needs of patients, clinicians, and partners. ITM Isotope Technologies Munich is based in Garching, DE, and has subsidiaries in Germany. The company aims to provide a new generation of radiomolecular precision therapeutics and diagnostics for hard-to-treat tumors. ITM has a broad precision oncology pipeline, including two phase III studies, combining the company's high-quality radioisotopes with a range of targeting molecules. The company benefits from its GMP infrastructure and expertise in sourcing, processing, and radiolabeling. The company was founded in 2004, and Steffen Schuster has been the CEO of the company since 2011. | Directeur Général | 01/12/2011 |
Anciens postes connus de Steffen Schuster
| Sociétés | Poste | Fin |
|---|---|---|
TVM Capital GmbH
 TVM Capital GmbH Investment ManagersFinance TVM Capital GmbH (TVMC) is an international venture capital firm headquartered in Munich, Germany. Founded in 1983, the firm was formerly known as Techno Venture Management. | Directeur Financier/CFO | 01/12/2011 |
alfabet AG
 alfabet AG Packaged SoftwareTechnology Services alfabet AG offers strategic information technology (IT) planning and business IT management solutions. It provides planningIT, an enterprise-wide software solution for business IT management; and business relationship management, enterprise architecture management, IT finance management and IT risk management solutions. The company was founded by Erik Masing Vorsitzender and Oleg Kovrigin in 1997 and is headquartered in Berlin, Germany. | Directeur/Membre du Conseil | - |
iTAC Software AG
 iTAC Software AG Packaged SoftwareTechnology Services iTAC Software AG provides software solutions. It offers serves the automotive industry, medical technologies, metal processing industry, energy and utilities industry, and electronics industry. The firm's products are manufacturing execution system (MES) suite, embedded systems, smart devices and enterprise framework. The company was founded by Dieter Meuser, Volker Burch and Christine Lahnstein in 1998 and is headquartered in Montabaur, Germany. | Directeur/Membre du Conseil | - |
Definiens AG
 Definiens AG Packaged SoftwareTechnology Services Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
TVM Capital GmbH
TVM Capital GmbH Investment ManagersFinance TVM Capital GmbH (TVMC) is an international venture capital firm headquartered in Munich, Germany. Founded in 1983, the firm was formerly known as Techno Venture Management. | Finance |
Definiens AG
Definiens AG Packaged SoftwareTechnology Services Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany. | Technology Services |
iTAC Software AG
iTAC Software AG Packaged SoftwareTechnology Services iTAC Software AG provides software solutions. It offers serves the automotive industry, medical technologies, metal processing industry, energy and utilities industry, and electronics industry. The firm's products are manufacturing execution system (MES) suite, embedded systems, smart devices and enterprise framework. The company was founded by Dieter Meuser, Volker Burch and Christine Lahnstein in 1998 and is headquartered in Montabaur, Germany. | Technology Services |
alfabet AG
alfabet AG Packaged SoftwareTechnology Services alfabet AG offers strategic information technology (IT) planning and business IT management solutions. It provides planningIT, an enterprise-wide software solution for business IT management; and business relationship management, enterprise architecture management, IT finance management and IT risk management solutions. The company was founded by Erik Masing Vorsitzender and Oleg Kovrigin in 1997 and is headquartered in Berlin, Germany. | Technology Services |
ITM Isotopen Technologien München AG
ITM Isotopen Technologien München AG Miscellaneous Commercial ServicesCommercial Services ITM Isotopen Technologien München AG develops diagnostic and therapeutic radionuclides and radiopharmaceuticals. Its products include EnolucinBeta, 188w/188re generator, 255AC/213Bi Generator, IQS-TS, IQS, consumables, and GMP Radiolabeling service. The company was founded in 2004 and is headquartered in Garching, Germany. | Commercial Services |
ITM Solucin GmbH
ITM Solucin GmbH Miscellaneous Commercial ServicesCommercial Services ITM Solucin GmbH provides scientific research and development services. The private company is based in Garching, Germany. The CEOs of the German company are Steffen Schuster, Klaus Maleck, Konstantin Zhernosekov. | Commercial Services |
ITM Isotope Technologies Munich SE
ITM Isotope Technologies Munich SE Pharmaceuticals: MajorHealth Technology ITM Isotope Technologies Munich SE is a German radiopharmaceutical biotech company that specializes in providing precise cancer radiotherapeutics and diagnostics to meet the needs of patients, clinicians, and partners. ITM Isotope Technologies Munich is based in Garching, DE, and has subsidiaries in Germany. The company aims to provide a new generation of radiomolecular precision therapeutics and diagnostics for hard-to-treat tumors. ITM has a broad precision oncology pipeline, including two phase III studies, combining the company's high-quality radioisotopes with a range of targeting molecules. The company benefits from its GMP infrastructure and expertise in sourcing, processing, and radiolabeling. The company was founded in 2004, and Steffen Schuster has been the CEO of the company since 2011. | Health Technology |
